Your browser doesn't support javascript.
loading
Infarct Size Following Treatment With Second- Versus Third-Generation P2Y12 Antagonists in Patients With Multivessel Coronary Disease at ST-Segment Elevation Myocardial Infarction in the CvLPRIT Study.
Khan, Jamal N; Greenwood, John P; Nazir, Sheraz A; Lai, Florence Y; Dalby, Miles; Curzen, Nick; Hetherington, Simon; Kelly, Damian J; Blackman, Daniel; Peebles, Charles; Wong, Joyce; Flather, Marcus; Swanton, Howard; Gershlick, Anthony H; McCann, Gerry P.
Afiliación
  • Khan JN; Department of Cardiovascular Sciences, University of Leicester, UK NIHR Leicester Cardiovascular Biomedical Research Unit, University Hospitals of Leicester NHS Trust, Glenfield Hospital, Leicester, UK jk211@le.ac.uk.
  • Greenwood JP; Multidisciplinary Cardiovascular Research Centre & The Division of Cardiovascular and Diabetes Research, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, UK.
  • Nazir SA; Department of Cardiovascular Sciences, University of Leicester, UK NIHR Leicester Cardiovascular Biomedical Research Unit, University Hospitals of Leicester NHS Trust, Glenfield Hospital, Leicester, UK.
  • Lai FY; Department of Cardiovascular Sciences, University of Leicester, UK NIHR Leicester Cardiovascular Biomedical Research Unit, University Hospitals of Leicester NHS Trust, Glenfield Hospital, Leicester, UK.
  • Dalby M; Royal Brompton and Harefield Foundation Trust, Harefield Hospital, Middlesex, UK.
  • Curzen N; University Hospital Southampton NHS Foundation Trust and University of Southampton, UK.
  • Hetherington S; Kettering General Hospital, Kettering, UK.
  • Kelly DJ; Royal Derby Hospital, Derby, UK.
  • Blackman D; Multidisciplinary Cardiovascular Research Centre & The Division of Cardiovascular and Diabetes Research, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, UK.
  • Peebles C; University Hospital Southampton NHS Foundation Trust and University of Southampton, UK.
  • Wong J; Royal Brompton and Harefield Foundation Trust, Harefield Hospital, Middlesex, UK.
  • Flather M; Norfolk and Norwich University Hospitals NHS Foundation Trust and Norwich Medical School, University of East Anglia, Norwich, UK.
  • Swanton H; The Heart Hospital, University College London Hospitals, London, UK.
  • Gershlick AH; Department of Cardiovascular Sciences, University of Leicester, UK NIHR Leicester Cardiovascular Biomedical Research Unit, University Hospitals of Leicester NHS Trust, Glenfield Hospital, Leicester, UK.
  • McCann GP; Department of Cardiovascular Sciences, University of Leicester, UK NIHR Leicester Cardiovascular Biomedical Research Unit, University Hospitals of Leicester NHS Trust, Glenfield Hospital, Leicester, UK.
J Am Heart Assoc ; 5(6)2016 05 31.
Article en En | MEDLINE | ID: mdl-27247336
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Inhibidores de Agregación Plaquetaria / Antagonistas del Receptor Purinérgico P2Y / Infarto del Miocardio con Elevación del ST Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Am Heart Assoc Año: 2016 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Inhibidores de Agregación Plaquetaria / Antagonistas del Receptor Purinérgico P2Y / Infarto del Miocardio con Elevación del ST Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Am Heart Assoc Año: 2016 Tipo del documento: Article País de afiliación: Reino Unido